Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S2 from Receptor Tyrosine Kinase Phosphorylation Pattern–Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment
  1. Home
  2. Publications
  3. Figure S2 from Receptor Tyrosine Kinase Phosphorylation Pattern–Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment

Figure S2 from Receptor Tyrosine Kinase Phosphorylation Pattern–Based Multidrug Combination Is an Effective Approach for Personalized Cancer Treatment

Authors:
  • XSXiaoxiao Sun
    Xiaoxiao Sun
  • QSQiaoling Song
    Qiaoling Song
  • LHLi He
    Li He
  • LYLei Yan
    Lei Yan
  • JLJingli Liu
    Jingli Liu
  • QZQing Zhang
    Qing Zhang
  • QYQiang Yu
    Qiang Yu

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.22503519.v1
Abstract
Targeting activated RTKs was essential to inhibit cancer cell growth.
Keywords
  • PHOSPHORYLATION PATTERN
  • BASED MULTIDRUG
  • RECEPTOR TYROSINE
  • TYROSINE KINASE
  • KINASE PHOSPHORYLATION
  • MULTIDRUG COMBINATION
  • EFFECTIVE APPROACH
  • TREATMENT TARGETING
  • PERSONALIZED CANCER
  • CANCER TREATMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.